Proteins / ECM2
ECM2
Extracellular matrix protein 2
Predicted 3D structure
AlphaFold model.
In plain language
ECM2 has barely been studied. The model's best guess: A secreted extracellular matrix-associated adhesion modulator that uses an N-terminal adhesive module and an extended leucine-rich repeat scaffold to bind integrins and assemble higher-order complexes. By anchoring within matrix networks and engaging cell-surface adhesion receptors, it promotes stable cell–matrix attachment and associated signaling, thereby shaping adhesion and migration behaviors in the extracellular space.
A secreted extracellular matrix-associated adhesion modulator that uses an N-terminal adhesive module and an extended leucine-rich repeat scaffold to bind integrins and assemble higher-order complexes.
Confidence: the model gives no confidence score, and this protein has no known function to compare with. Treat it as a hypothesis.
Protein domains
Known building blocks found by InterPro, placed along the 699 amino acids of the chain. Hover or tap a block for details.
- Leucine-rich repeat domain superfamily · 315–408
- Leucine-rich repeat domain superfamily · 409–479
- Leucine-rich repeat domain superfamily · 480–550
- Leucine-rich repeat domain superfamily · 551–699
- VWFC domain · 101–158
- Extracellular matrix protein 2 · 1–699
- Leucine-rich repeat · 343–405
- Leucine-rich repeat, typical subtype · 343–365
- Leucine-rich repeat, typical subtype · 366–391
- Leucine-rich repeat, typical subtype · 392–415
- Leucine-rich repeat, typical subtype · 416–436
- Leucine-rich repeat, typical subtype · 437–462
- Leucine-rich repeat, typical subtype · 463–486
- Leucine-rich repeat · 486–557
- Leucine-rich repeat, typical subtype · 488–507
- Leucine-rich repeat, typical subtype · 535–557
- Leucine-rich repeat, typical subtype · 558–578
- Leucine-rich repeat, typical subtype · 607–629
- Leucine-rich repeat · 609–630
- Leucine rich repeat 4 · 609–646
- Leucine-rich repeat, typical subtype · 630–654
- Leucine-rich repeat, typical subtype · 660–684
Predicted function
Model summary
A secreted extracellular matrix-associated adhesion modulator that uses an N-terminal adhesive module and an extended leucine-rich repeat scaffold to bind integrins and assemble higher-order complexes. By anchoring within matrix networks and engaging cell-surface adhesion receptors, it promotes stable cell–matrix attachment and associated signaling, thereby shaping adhesion and migration behaviors in the extracellular space.
Predicted Gene Ontology terms
Model reasoning
How the model got to its answer
- 01
I begin by dissecting the domain architecture.
An N-terminal IPR001007 VWFC domain (von Willebrand factor type C; residues 101–158) precedes a long series of leucine-rich repeat (LRR) modules that dominate the remainder of the protein. The LRR region is supported by multiple concordant signatures: IPR032675 Leucine-rich repeat domain superfamily spans residues 315–408, 409–479, 480–550, and 551–699, collectively defining a continuous LRR-based scaffold. Within this scaffold, there is a dense array of LRR repeats annotated by IPR001611 (residues 343–405 and 486–557) and by IPR003591 typical LRR subtype repeats across residues 343–436 and 488–654, indicating a curved solenoid surface specialized for protein–protein recognition. The VWFC module is a hallmark of secreted extracellular proteins that mediate matrix interactions and growth factor or integrin-associated assemblies.
- 02
This ordered architecture—an N-terminal VWFC adhesive module followed by an extended LRR solenoid—causally establishes a high-affinity, multivalent binding platform.
LRR arrays create concave binding grooves that capture extracellular ligands and receptors; in this context, the architecture is ideally suited to engage integrins. This directly supports the molecular function formalized as GO:0005178 integrin binding. The VWFC domain can nucleate extracellular complex formation and matrix tethering, while the LRR scaffold stabilizes and specifies integrin interactions.
- 03
Integrin binding positions the protein squarely within adhesion biology.
By coupling integrin engagement to extracellular matrix anchorage, the protein promotes stable cell–matrix contacts and signaling. This mechanistic coupling drives the biological process represented by GO:0007160 cell-matrix adhesion. The VWFC-to-LRR pipeline thus translates adhesive recognition into durable adhesion and downstream signaling.
- 04
The presence of a VWFC domain and the extensive extracellular LRR array argue for secretion and matrix association.
This architecture lacks transmembrane features and instead favors soluble extracellular deployment. Therefore, the cellular component is the extracellular matrix, aligning with GO:0031012 extracellular matrix. The experimentally observed secreted status is mechanistically explained by the VWFC-mediated secretion/matrix-binding system and the adhesive LRR scaffold.
- 05
From this foundation, a mechanistic hypothesis emerges.
The VWFC domain seeds assembly of extracellular complexes and anchors the protein within matrix networks. The LRR solenoid then presents an integrin-binding surface that modulates adhesion strength and signaling thresholds. Likely interaction partners include fibrillar matrix components and integrin heterodimers that govern adhesion and migration. I therefore hypothesize preferential association with extracellular matrix proteins such as fibronectin and collagens, and with integrins that govern cell–matrix adhesion dynamics. Together, these interactions would enable the protein to tune adhesion, migration, and matrix remodeling in the extracellular space.
Technical details
InterPro entries
- IPR032675 Leucine-rich repeat domain superfamily homologous superfamily · 315–408
- IPR032675 Leucine-rich repeat domain superfamily homologous superfamily · 409–479
- IPR032675 Leucine-rich repeat domain superfamily homologous superfamily · 480–550
- IPR032675 Leucine-rich repeat domain superfamily homologous superfamily · 551–699
- IPR001007 VWFC domain domain · 101–158
- IPR043184 Extracellular matrix protein 2 family · 1–699
- IPR001611 Leucine-rich repeat repeat · 343–405
- IPR003591 Leucine-rich repeat, typical subtype repeat · 343–365
- IPR003591 Leucine-rich repeat, typical subtype repeat · 366–391
- IPR003591 Leucine-rich repeat, typical subtype repeat · 392–415
- IPR003591 Leucine-rich repeat, typical subtype repeat · 416–436
- IPR003591 Leucine-rich repeat, typical subtype repeat · 437–462
- IPR003591 Leucine-rich repeat, typical subtype repeat · 463–486
- IPR001611 Leucine-rich repeat repeat · 486–557
- IPR003591 Leucine-rich repeat, typical subtype repeat · 488–507
- IPR003591 Leucine-rich repeat, typical subtype repeat · 535–557
- IPR003591 Leucine-rich repeat, typical subtype repeat · 558–578
- IPR003591 Leucine-rich repeat, typical subtype repeat · 607–629
- IPR001611 Leucine-rich repeat repeat · 609–630
- IPR025875 Leucine rich repeat 4 repeat · 609–646
- IPR003591 Leucine-rich repeat, typical subtype repeat · 630–654
- IPR003591 Leucine-rich repeat, typical subtype repeat · 660–684
Sources
- Sequence: UniProt O94769
- Structure: AlphaFold DB (PDB file)
- Domains: InterPro
- Dark protein list: Pharos (Tdark)
Method
BioReason-Pro with the ESM3 protein language model (esm3-sm-open-v1). How the atlas is made →